LISKOVA, Alena, Lenka KOKLESOVA, Marek SAMEC, Elizabeth VARGHESE, Mariam ABOTALEB, Samson Mathews SAMUEL, Karel ŠMEJKAL, Kamil BIRINGER, Martin PETRAS, Dana BLAHUTOVA, Ondrej BUGOS, Martin PEC, Marian ADAMKOV, Dietrich BUSSELBERG, Rachele CICCOCIOPPO, Mariusz ADAMEK, Luis RODRIGO, Martin CAPRNDA, Peter KRUŽLIAK a Peter KUBATKA. Implications of flavonoids as potential modulators of cancer neovascularity. Journal of cancer research and clinical oncology. Germany: Springer-Verlag, 2020, roč. 146, č. 12, s. 3079-3096. ISSN 0171-5216. Dostupné z: https://dx.doi.org/10.1007/s00432-020-03383-8.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Implications of flavonoids as potential modulators of cancer neovascularity
Autoři LISKOVA, Alena (703 Slovensko), Lenka KOKLESOVA (703 Slovensko), Marek SAMEC (703 Slovensko), Elizabeth VARGHESE (634 Katar), Mariam ABOTALEB (634 Katar), Samson Mathews SAMUEL (634 Katar), Karel ŠMEJKAL (203 Česká republika, domácí), Kamil BIRINGER (703 Slovensko), Martin PETRAS (703 Slovensko), Dana BLAHUTOVA (703 Slovensko), Ondrej BUGOS (703 Slovensko), Martin PEC (703 Slovensko), Marian ADAMKOV (703 Slovensko), Dietrich BUSSELBERG (276 Německo), Rachele CICCOCIOPPO (380 Itálie), Mariusz ADAMEK (616 Polsko), Luis RODRIGO (724 Španělsko), Martin CAPRNDA (703 Slovensko), Peter KRUŽLIAK (703 Slovensko, garant, domácí) a Peter KUBATKA (703 Slovensko).
Vydání Journal of cancer research and clinical oncology, Germany, Springer-Verlag, 2020, 0171-5216.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30204 Oncology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.553
Kód RIV RIV/00216224:14110/20:00116475
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1007/s00432-020-03383-8
UT WoS 000567736000003
Klíčová slova anglicky Cancer; Tumor angiogenesis; Neovascularity; Flavonoids; VEGF; Anti-cancer therapy
Štítky 14110121, podil, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 4. 5. 2021 13:04.
Anotace
Purpose The formation of new blood vessels from previous ones, angiogenesis, is critical in tissue repair, expansion or remodeling in physiological processes and in various pathologies including cancer. Despite that, the development of anti-angiogenic drugs has great potential as the treatment of cancer faces many problems such as development of the resistance to treatment or an improperly selected therapy approach. An evaluation of predictive markers in personalized medicine could significantly improve treatment outcomes in many patients. Methods This comprehensive review emphasizes the anticancer potential of flavonoids mediated by their anti-angiogenic efficacy evaluated in current preclinical and clinical cancer research. Results and conclusion Flavonoids are important groups of phytochemicals present in common diet. Flavonoids show significant anticancer effects. The anti-angiogenic effects of flavonoids are currently a widely discussed topic of preclinical cancer research. Flavonoids are able to regulate the process of tumor angiogenesis through modulation of signaling molecules such as VEGF, MMPs, ILs, HIF or others. However, the evaluation of the anti-angiogenic potential of flavonoids within the clinical studies is not frequently discussed and is still of significant scientific interest.
VytisknoutZobrazeno: 14. 5. 2024 00:47